{
  "title": "Appraisal of hydatidiform mole incidence and registration rates in Ireland following the establishment of a National Gestational Trophoblastic Disease RegistryAtypical placental site nodule (APSN) and association with malignant gestational trophoblastic disease; a Clinicopathologic study of 21 casesMolecular analyses of chorionic-type intermediate trophoblastic lesions: atypical placental site nodules are closer to placental site nodules than epithelioid trophoblastic tumorsAncillary studies for precision diagnosis of hydatidiform molesTreatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the charing cross hospital, 2000\u20132009Advances in the diagnosis and early management of gestational Trophoblastic diseaseGenetic studies on hydatidiform moles I the origin of partial molesHuman triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform moleChanging presentation of complete hydatidiform mole at the New England trophoblastic disease center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasiaGenetic mapping of a maternal locus responsible for familial hydatidiform molesThe relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcomeUterine gestational choriocarcinoma developing after a long latent period in a postmenopausal woman: the value of DNA polymorphism studiesTrends in incidence for gestational trophoblastic disease over the last 20 years in a population-based studyMaternal age-related rates of gestational trophoblastic diseaseGestational trophoblastic disease in the Asian population of Northern England and North WalesEpidemiology and aetiology of gestational trophoblastic diseasesGestational trophoblastic disease: current evaluation and managementGestational trophoblast disease: clinical presentation and treatmentInterobserver and intraobserver variability in the diagnosis of hydatidiform moleHydatidiform moles: ancillary techniques to refine diagnosisDiscrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57 KIP2p57-discordant villi in hydropic products of conception: a clinicopathological study of 70 casesMorphology combined with HER2 D-DISH ploidy analysis to diagnose partial hydatidiform mole: an evaluation audit using molecular genotypingAccuracy of hydatidiform mole diagnosis using morphology and ploidy determination with HER2 D-DISH compared to molecular genotypingDiagnosis, staging and treatment of patients with gestational trophoblastic disease: national clinical guideline No.13Diagnosis and management of gestational trophoblastic disease: 2021 updateAssessment of current follow\u2010up for complete molar pregnancies: a single centre reviewLow risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancyLow risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancyon behalf of the Royal College of Obstetricians andGynaecologists. Management of Gestational Trophoblastic DiseaseWorldwide survey of the results of treating gestational trophoblastic diseaseProgress to international harmonisation of care and future developmentsGestational trophoblastic neoplasia lethality among Brazilian women: a retrospective national cohort studyEuropean Journal of obstetrics & gynecology and reproductive biology challenging gestational trophoblastic disease cases and mimics: an exemplar for the management of rare tumoursExperience of women on the Irish national gestational trophoblastic disease registryA novel scoring system provides high separation of diploidy and triploidy to aid partial hydatidiform mole diagnosis: an adaption of HER2 D-DISH for ploidy analysisPerinatal Statistics report 2019South/Southwest Hospital Group Annual Report 2017South/Southwest Hospital Group Annual Report 2018South/Southwest Hospital Group Annual Report 2019Partial hydatidiform mole: a common but underdiagnosed condition. A 3-year retrospective clinicopathological and DNA flow cytometric analysisHas the incidence of molar pregnancy changed over the last 10 yearsRisk of partial and complete hydatidiform molar pregnancy in relation to maternal ageGestational trophoblastic diseaseRecent advances in gestational trophoblastic diseaseDNA genotyping of suspected partial hydatidiform moles detects clinically significant aneuploidyPractical guidelines of the EOTTD for pathological and genetic diagnosis of hydatidiform molesIncrease in the incidence of gestational trophoblastic disease in the NetherlandsHigh incidence of gestational trophoblastic disease in a third-level University-hospital, Italy: a retrospective cohort studyA reappraisal of the incidence of placental hydatidiform mole using selective molecular genotypingAn examination of care received by women with recurrent miscarriage and infertility against guideline-based key performance indicatorsPerinatal Mortality in Ireland: Biennial Report 2018/2019The diagnosis and prognosis of molar pregnancy: the experience of the National referral centre in LondonPersistent gestational trophoblastic disease is rarely, if ever, derived from non-molar first-trimester miscarriageGestational trophoblastic neoplasia after human chorionic gonadotropin normalization following molar pregnancy: a systematic review and meta-analysisTen steps to establish a national centre for gestational trophoblastic diseaseDecreasing incidence of registered hydatidiform moles in Denmark 1999\u20132014Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort studyRecent changes of the incidence of complete and partial mole in Chiba prefectureIncidence of gestational trophoblastic disease in South Korea: a longitudinal, population-based study",
  "pmcid": "12703346",
  "features": {
    "sample_size": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "randomization": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "blinding": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "allocation_concealment": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "interaction_subgroup": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "variable_definitions": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "analysis_principles": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "itt_details": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "software": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "error_measures": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "multiplicity_correction": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "normality_checks": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "p_values": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "confidence_intervals": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "comparative_stats": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "non_parametric": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "advanced_modeling": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "assumption_checks": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "survival_analysis": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "regression_and_models": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "reporting_guidelines": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "data_types": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "dependency": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "clustering": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "missing_data": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "effect_size": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "post_hoc": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "baseline_reporting": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "advanced_modeling_extra": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "excluded"
      ],
      "examples": [
        {
          "match": "excluded",
          "context": "ated that an \u2018HM could not be excluded\u2019 or where cases were \u2018suspici"
        }
      ]
    },
    "systematic_review_metrics": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "diagnostic_metrics": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "model_details": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "domain_indicators": {
      "present": true,
      "count": 3,
      "unique_matches": [
        "immunohistochemistry",
        "staining"
      ],
      "examples": [
        {
          "match": "immunohistochemistry",
          "context": "; HM, hydatidiform mole; IHC, immunohistochemistry; n, number; PHM, partial HM;"
        },
        {
          "match": "staining",
          "context": "the study period, HER2 DDISH staining quality was monitored by inte"
        },
        {
          "match": "staining",
          "context": "cillary techniques (p57 immunostaining, DNA ploidy and STR genotypin"
        }
      ]
    }
  },
  "feedback": {
    "overall_score": 10.0,
    "rigor_rating": "High",
    "critical_gaps": [],
    "strengths": [
      {
        "message": "Analysis context identifies basic science or bioinformatics (Softened clinical trial requirements).",
        "evidence": "Detected term: 'immunohistochemistry'"
      },
      {
        "message": "Exclusion criteria explicitly defined (transparency).",
        "evidence": "...ated that an \u2018HM could not be excluded\u2019 or where cases were \u2018suspici..."
      }
    ],
    "actionable_recommendations": [],
    "deterministic_audit": true
  }
}